Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday’s Mid-Day Session
Gainers
Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.
Northland Capital Markets Maintains Outperform on Nabriva Therapeutics. Price Adjusts to $18.
Northland Capital Markets analyst Carl Byrnes maintains Nabriva Therapeutics (NASDAQ:NBRV) with a Outperform. Price Adjusts to $18
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday’s Mid-Day Session
Gainers
HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
Recap: Nabriva Therapeutics Q2 Earnings
Nabriva Therapeutics (NASDAQ:NBRV) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.